Switzerland-based AI biotech startup Cradle has secured USD 24 million in a Series A funding round led by Index Ventures, with participation from Kindred Capital, Chris Gibson, Tom Glocer, and other existing investors. This brings the total funds raised by the company to USD 33 million.
The proceeds will be utilized to expand the team, boost sales, and construct additional engineering and lab facilities.
Founded in 2022, Cradle is involved in designing proteins using GenAI that focus on understanding molecular structures, allowing a quicker, more cost-effective process of protein design. The firm employs natural language processing and proprietary data to anticipate alterations needed in the protein's genetic code for enhanced function and stability. The company also offers AI-assisted design tools that can predict a protein’s 3D structure, generate new sequences with improved thermostability and optimize codons.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.